Biotie Therapies - Changes board/management/auditors

Organizational meeting of the Board of Directors of Biotie Therapies Corp.

BIOTIE THERAPIES CORP.         STOCK EXCHANGE RELEASE          7 February 2011,
at 6.15  p.m.

Organizational meeting of the Board of Directors of Biotie Therapies Corp.

Board of Directors of Biotie Therapies Corp. ("Biotie" or the "Company") held
its organizational meeting on 7 February 2011.

Peter Fellner continues as the Chairman of the Board of Directors. The Board
elected Bradley J. Bolzon as Deputy Chairman of the Board. The Board resolved
that the Company shall continue to have two committees, Audit Committee as well
as Nomination and Remuneration Committee. Members of the Audit Committee are
Bernd Kastler (Chairman), Merja Karhapää, Piet Serrure and Andrew Schwab.
Members of the Nomination and Remuneration Committee are Peter Fellner
(Chairman), Bradley J. Bolzon, William Burns and James Shannon The term of
office of the Board expires at the end of the Annual General Meeting following
their election.

In Turku, 7 February 2011

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com
www.biotie.com


Distribution:
NASDAQ OMX Helsinki Ltd
Main Media




[HUG#1486221]